Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 57
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07180862 | A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants | ||
| NCT04151329 | A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor | ||
| NCT06094179 | Evaluate the Safety, Tolerability of BAT6026 | ||
| NCT05073484 | Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients | ||
| NCT05141994 | Clinical Study on the Efficacy and Safety of BAT5906 Injection | ||
| NCT04152148 | A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients | ||
| NCT03606876 | Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects | ||
| NCT05155722 | Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors | ||
| NCT03830203 | Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate | ||
| NCT05378737 | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection | ||
| NCT06111196 | Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects | ||
| NCT05865574 | A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection | ||
| NCT03030430 | Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects | ||
| NCT05848466 | Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients | ||
| NCT05439629 | Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration | ||
| NCT05116709 | Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors | ||
| NCT05405621 | Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009 | ||
| NCT03884517 | Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer | ||
| NCT05518695 | Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects | ||
| NCT04371185 | Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects | ||
| NCT03329911 | A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer | ||
| NCT05120375 | Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China | ||
| NCT04728360 | Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis | ||
| NCT05576454 | Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects | ||
| NCT04432766 | A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients | ||
| NCT05620017 | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection | ||
| NCT04152759 | Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects | ||
| NCT05377944 | Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients | ||
| NCT05109650 | Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients | ||
| NCT05105971 | Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China | ||
| NCT05879627 | To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors | ||
| NCT05332730 | A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi® | ||
| NCT05200013 | BAT7104 in Patients With Advanced Solid Tumours | ||
| NCT07499700 | A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis | ||
| NCT05148325 | Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors | ||
| NCT06341114 | A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors | ||
| NCT05414136 | Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 | ||
| NCT06376136 | A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors | ||
| NCT06545617 | A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer | ||
| NCT05180526 | Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) | ||
| NCT05046431 | Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis | ||
| NCT05803187 | Clinical Study of Stage IV Psoriasis in Children With Geleli | ||
| NCT04146285 | A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders | ||
| NCT06280196 | A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC | ||
| NCT05767060 | BAT7104 Injection in Patients With Advanced Malignant Tumors. | ||
| NCT04189211 | A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients | ||
| NCT06044350 | A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders | ||
| NCT04711343 | Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects | ||
| NCT04772105 | Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema | ||
| NCT06321068 | BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer |
